TRICUS STUDY - Safety and Efficacy of the TricValve® Device

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

September 12, 2018

Primary Completion Date

September 4, 2020

Study Completion Date

November 15, 2021

Conditions
Severe Tricuspid Regurgitation
Interventions
DEVICE

TricValve® System

The TricValve® Delivery System is inserted from the femoral vein to access the inferior vena cava (IVC) and superior vena cava (SVC) of the heart under fluoroscopy guidance. The appropriately sized TricValve® is unsheathed at the implantation site and positions itself as per the anatomy - self expanding frame.

Trial Locations (1)

Unknown

LSMUH Kauno Kliniko, Kaunas

All Listed Sponsors
lead

P+F Products + Features GmbH

INDUSTRY

NCT03723239 - TRICUS STUDY - Safety and Efficacy of the TricValve® Device | Biotech Hunter | Biotech Hunter